Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Samantha MaWhinney

Concepts (499)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
81
2024
2459
4.920
 Why?
Anti-HIV Agents
37
2022
664
4.110
 Why?
Adenine
14
2022
223
2.110
 Why?
Organophosphates
11
2022
90
1.940
 Why?
Tenofovir
17
2022
200
1.910
 Why?
Emtricitabine
14
2021
146
1.870
 Why?
Acquired Immunodeficiency Syndrome
10
2023
224
1.760
 Why?
HIV-1
29
2021
776
1.650
 Why?
Dried Blood Spot Testing
8
2022
68
1.410
 Why?
Medication Adherence
15
2022
556
1.210
 Why?
Pre-Exposure Prophylaxis
7
2021
174
0.790
 Why?
Viral Load
19
2022
419
0.740
 Why?
Directly Observed Therapy
1
2017
14
0.630
 Why?
Middle Aged
66
2023
27617
0.600
 Why?
Adult
62
2023
31512
0.580
 Why?
Anti-Retroviral Agents
5
2019
208
0.550
 Why?
Aging
9
2023
1670
0.530
 Why?
Humans
122
2024
118972
0.520
 Why?
Leukocytes, Mononuclear
8
2021
509
0.520
 Why?
Male
77
2023
57801
0.510
 Why?
Pulmonary Disease, Chronic Obstructive
1
2023
1137
0.500
 Why?
Female
77
2022
61564
0.480
 Why?
Unsafe Sex
2
2012
57
0.470
 Why?
Viremia
6
2022
132
0.470
 Why?
Cytochrome P-450 CYP3A
2
2012
60
0.450
 Why?
Lamivudine
2
2012
59
0.430
 Why?
Zidovudine
2
2012
77
0.430
 Why?
Exercise
6
2022
1657
0.420
 Why?
T-Lymphocytes, Cytotoxic
6
2014
158
0.410
 Why?
CD8-Positive T-Lymphocytes
8
2018
702
0.410
 Why?
Sofosbuvir
4
2022
52
0.410
 Why?
Oligopeptides
2
2012
252
0.400
 Why?
Prospective Studies
23
2022
6471
0.390
 Why?
Atazanavir Sulfate
4
2016
41
0.380
 Why?
Models, Statistical
5
2022
636
0.380
 Why?
Sustained Virologic Response
3
2019
33
0.380
 Why?
Mobile Applications
2
2022
147
0.370
 Why?
HIV Integrase Inhibitors
2
2024
60
0.370
 Why?
Receptors, CCR5
6
2013
54
0.370
 Why?
CD4-Positive T-Lymphocytes
9
2016
984
0.360
 Why?
Emigrants and Immigrants
1
2012
115
0.360
 Why?
Dideoxynucleotides
2
2012
14
0.360
 Why?
Cytidine Triphosphate
2
2012
15
0.360
 Why?
Pyridines
2
2012
440
0.350
 Why?
Phosphorous Acids
2
2019
12
0.350
 Why?
Levonorgestrel
2
2012
32
0.350
 Why?
Frailty
2
2022
116
0.340
 Why?
Antiviral Agents
3
2019
654
0.340
 Why?
Quality of Life
7
2023
2366
0.330
 Why?
Sarcoma, Kaposi
3
2022
73
0.320
 Why?
Antiretroviral Therapy, Highly Active
8
2019
260
0.320
 Why?
Exercise Therapy
3
2020
355
0.310
 Why?
Aged
26
2023
19657
0.300
 Why?
Gonadal Steroid Hormones
1
2008
122
0.300
 Why?
Prion Diseases
1
2006
11
0.290
 Why?
Deoxyadenine Nucleotides
2
2016
13
0.290
 Why?
Creutzfeldt-Jakob Syndrome
1
2006
15
0.290
 Why?
Deoxycytosine Nucleotides
2
2016
11
0.290
 Why?
Wasting Disease, Chronic
1
2006
19
0.290
 Why?
Inflammation
5
2021
2566
0.290
 Why?
Coronary Artery Bypass
7
2004
209
0.280
 Why?
Lymph Nodes
6
2017
455
0.280
 Why?
Young Adult
16
2020
10793
0.270
 Why?
Simian Immunodeficiency Virus
2
2016
98
0.260
 Why?
Gene Expression
2
2014
1489
0.260
 Why?
Simian Acquired Immunodeficiency Syndrome
2
2016
98
0.260
 Why?
Cross-Over Studies
4
2020
456
0.260
 Why?
Body Composition
4
2024
653
0.260
 Why?
Lymphocyte Activation
9
2018
1067
0.260
 Why?
Contraceptives, Postcoital
1
2004
2
0.250
 Why?
HIV
4
2019
210
0.250
 Why?
CD4 Lymphocyte Count
10
2020
267
0.250
 Why?
Population Surveillance
3
2002
413
0.240
 Why?
Advance Care Planning
2
2021
191
0.240
 Why?
Cohort Studies
8
2023
5116
0.240
 Why?
Cytokines
3
2009
1900
0.230
 Why?
Physical Fitness
2
2015
179
0.230
 Why?
Patient Dropouts
2
2015
66
0.230
 Why?
Lipopolysaccharide Receptors
2
2021
88
0.230
 Why?
HIV Integrase
1
2024
66
0.230
 Why?
Fluorenes
2
2020
37
0.220
 Why?
Telerehabilitation
1
2022
26
0.210
 Why?
RNA, Viral
9
2014
572
0.210
 Why?
HIV Seropositivity
3
2012
111
0.210
 Why?
High-Intensity Interval Training
1
2022
18
0.210
 Why?
Lymphoid Tissue
3
2008
65
0.210
 Why?
Hepatitis C
2
2022
217
0.210
 Why?
Benzimidazoles
2
2020
140
0.210
 Why?
Cell Phone
1
2022
81
0.210
 Why?
Hair
2
2018
68
0.200
 Why?
Protease Inhibitors
2
2020
102
0.190
 Why?
Fees and Charges
1
2000
10
0.190
 Why?
Polyphosphates
4
2022
32
0.190
 Why?
Mitochondria, Muscle
1
2021
97
0.190
 Why?
Ritonavir
2
2012
70
0.190
 Why?
Hyperlipidemias
1
2021
128
0.180
 Why?
Advance Directives
1
2021
62
0.180
 Why?
Interleukin-10
2
2021
306
0.180
 Why?
Costs and Cost Analysis
1
2000
202
0.180
 Why?
ADP-ribosyl Cyclase 1
4
2013
36
0.180
 Why?
Biomarkers
6
2021
3588
0.180
 Why?
Thymine Nucleotides
2
2016
15
0.170
 Why?
Myocardial Ischemia
1
2000
251
0.170
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2018
14
0.170
 Why?
Transgender Persons
1
2021
135
0.160
 Why?
Colorado
7
2022
4196
0.160
 Why?
Cytomegalovirus Infections
2
2015
187
0.160
 Why?
Hepatitis C, Chronic
2
2019
151
0.160
 Why?
Virus Replication
5
2017
405
0.160
 Why?
Blood Chemical Analysis
4
2019
95
0.160
 Why?
Drug Resistance, Viral
1
2019
98
0.160
 Why?
Simeprevir
1
2018
9
0.160
 Why?
Longitudinal Studies
5
2020
2513
0.160
 Why?
Raltegravir Potassium
2
2015
16
0.160
 Why?
Heterocyclic Compounds, 3-Ring
1
2018
28
0.160
 Why?
Length of Stay
4
2000
1032
0.160
 Why?
Epitopes, T-Lymphocyte
4
2008
170
0.150
 Why?
Viral Tropism
1
2017
24
0.150
 Why?
Pharmacogenetics
2
2016
151
0.150
 Why?
Sleep Wake Disorders
1
2020
241
0.150
 Why?
AIDS-Related Opportunistic Infections
3
2007
113
0.150
 Why?
Pyrophosphatases
1
2016
22
0.150
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2021
387
0.150
 Why?
Deoxyguanine Nucleotides
1
2016
8
0.150
 Why?
Germinal Center
1
2016
47
0.150
 Why?
Academic Medical Centers
1
2019
422
0.140
 Why?
T-Lymphocytes, Helper-Inducer
1
2017
130
0.140
 Why?
Genitalia
1
2016
27
0.140
 Why?
Alanine
3
2021
102
0.140
 Why?
Motor Activity
4
2015
660
0.140
 Why?
Vaccines, DNA
2
2008
32
0.140
 Why?
Risk Factors
11
2021
9000
0.140
 Why?
Ribavirin
1
2016
88
0.140
 Why?
AIDS Vaccines
2
2008
44
0.140
 Why?
HIV Protease Inhibitors
2
2016
64
0.140
 Why?
Muscle Strength
1
2018
283
0.140
 Why?
Purines
1
2016
161
0.130
 Why?
Disease Transmission, Infectious
2
2018
56
0.130
 Why?
Mental Health Services
1
2019
331
0.130
 Why?
Case-Control Studies
7
2016
3171
0.130
 Why?
Biometry
2
2011
65
0.130
 Why?
Rectum
1
2016
157
0.130
 Why?
Antibodies, Viral
3
2015
542
0.130
 Why?
HLA-DR Antigens
3
2012
224
0.130
 Why?
Sexual and Gender Minorities
1
2017
137
0.130
 Why?
Genitalia, Female
1
2015
40
0.130
 Why?
Organophosphonates
1
2015
94
0.120
 Why?
T-Lymphocytes, Regulatory
1
2017
359
0.120
 Why?
Probability
2
2011
305
0.120
 Why?
Telemedicine
1
2022
664
0.120
 Why?
Calcifediol
1
2014
29
0.120
 Why?
Deoxycytidine
1
2015
136
0.120
 Why?
Disease Progression
4
2015
2490
0.120
 Why?
Gastrointestinal Microbiome
1
2021
548
0.120
 Why?
T-Lymphocyte Subsets
3
2015
396
0.120
 Why?
Membrane Glycoproteins
3
2013
446
0.120
 Why?
Decision Making
1
2021
809
0.120
 Why?
Calcitriol
1
2014
55
0.120
 Why?
Immunoglobulin Variable Region
1
2014
71
0.120
 Why?
Patient Compliance
1
2017
537
0.120
 Why?
Antimicrobial Cationic Peptides
1
2014
78
0.120
 Why?
Adolescent
13
2020
18480
0.120
 Why?
Microbiota
1
2021
656
0.120
 Why?
Chromatography, Liquid
3
2019
355
0.110
 Why?
Immunoglobulin G
2
2015
788
0.110
 Why?
Infectious Disease Transmission, Vertical
1
1994
156
0.110
 Why?
Emergency Service, Hospital
1
2004
1864
0.110
 Why?
Immunologic Factors
1
2015
225
0.110
 Why?
Tandem Mass Spectrometry
3
2019
421
0.110
 Why?
Spleen
1
2014
510
0.110
 Why?
Hepatitis A Vaccines
1
2012
15
0.110
 Why?
Dendritic Cells
2
2008
442
0.110
 Why?
Diabetes Mellitus
1
2020
942
0.110
 Why?
Hepatitis A
1
2012
27
0.110
 Why?
Time Factors
7
2019
6412
0.110
 Why?
Benzoxazines
1
2012
28
0.110
 Why?
Cell Movement
3
2016
896
0.100
 Why?
Cervix Uteri
1
2012
48
0.100
 Why?
Retrospective Studies
9
2021
12978
0.100
 Why?
Muscle, Skeletal
1
2021
1515
0.100
 Why?
Sarcopenia
1
2013
72
0.100
 Why?
Marijuana Smoking
1
2015
220
0.100
 Why?
B-Lymphocytes
1
2016
770
0.100
 Why?
Haplotypes
2
2012
473
0.100
 Why?
Contraceptive Agents
1
2012
57
0.100
 Why?
Mental Disorders
1
2019
939
0.100
 Why?
Sex Factors
5
2018
1781
0.100
 Why?
Contraceptive Agents, Female
1
2012
65
0.100
 Why?
CD4 Antigens
1
2011
126
0.100
 Why?
HIV Seronegativity
1
2010
24
0.100
 Why?
Antacids
1
2010
15
0.100
 Why?
Polymorphism, Genetic
2
2016
642
0.100
 Why?
Hypertension, Pulmonary
1
2022
1794
0.100
 Why?
Pyrrolidinones
1
2010
25
0.100
 Why?
Cross-Sectional Studies
8
2019
4552
0.090
 Why?
Accidental Falls
1
2012
154
0.090
 Why?
Osteoporosis
1
2013
229
0.090
 Why?
Predictive Value of Tests
4
2019
1868
0.090
 Why?
Postmenopause
1
2012
305
0.090
 Why?
Diphosphates
2
2021
16
0.090
 Why?
Herpesvirus 8, Human
2
2000
68
0.090
 Why?
Cytomegalovirus
2
2015
144
0.090
 Why?
Zimbabwe
3
2022
39
0.090
 Why?
Drug Interactions
3
2019
352
0.090
 Why?
Cytotoxicity Tests, Immunologic
3
2003
49
0.080
 Why?
Demography
2
2022
274
0.080
 Why?
Polymorphism, Single Nucleotide
2
2016
2062
0.080
 Why?
Hepacivirus
2
2022
230
0.080
 Why?
Lung Diseases
1
2015
718
0.080
 Why?
Linear Models
3
2020
827
0.080
 Why?
Healthy Volunteers
2
2018
201
0.080
 Why?
Plasma
1
2009
224
0.080
 Why?
Multivariate Analysis
7
2007
1474
0.080
 Why?
Interleukin-12
2
1998
110
0.070
 Why?
Hospitals, Veterans
3
2004
246
0.070
 Why?
Adipocytes
1
2008
199
0.070
 Why?
Deer
1
2006
24
0.070
 Why?
Managed Care Programs
1
2007
135
0.070
 Why?
Sequence Analysis, DNA
1
2009
755
0.070
 Why?
Self Report
2
2021
699
0.070
 Why?
Comorbidity
3
2019
1527
0.070
 Why?
Interferon-gamma
3
2008
736
0.070
 Why?
Therapeutic Equivalency
2
2018
18
0.070
 Why?
Interleukin-6
2
2021
688
0.070
 Why?
Physicians, Family
1
2007
206
0.070
 Why?
Preventive Health Services
1
2007
135
0.070
 Why?
Treatment Outcome
9
2018
9342
0.070
 Why?
Macaca mulatta
2
2016
153
0.070
 Why?
T-Lymphocytes
3
2005
1774
0.070
 Why?
Incidence
4
2012
2424
0.060
 Why?
Immunoenzyme Techniques
1
2005
195
0.060
 Why?
Immunologic Memory
2
2009
313
0.060
 Why?
Hospitalization
3
2022
1785
0.060
 Why?
Licensure, Pharmacy
1
2004
1
0.060
 Why?
Northern Ireland
1
2004
8
0.060
 Why?
Area Under Curve
2
2018
296
0.060
 Why?
Molecular Sequence Data
1
2009
2871
0.060
 Why?
Pilot Projects
3
2022
1419
0.060
 Why?
New York City
2
1994
75
0.060
 Why?
Programmed Cell Death 1 Receptor
2
2016
197
0.060
 Why?
Surveys and Questionnaires
2
2014
4708
0.060
 Why?
HIV Antibodies
2
2014
50
0.060
 Why?
Fluorescent Antibody Technique
3
2015
410
0.060
 Why?
Odds Ratio
3
2014
996
0.060
 Why?
Survival Analysis
3
2015
1267
0.060
 Why?
Patient Satisfaction
1
2007
610
0.060
 Why?
Conserved Sequence
1
2003
219
0.060
 Why?
Mutation
1
2014
3457
0.060
 Why?
Ki-67 Antigen
2
2017
108
0.060
 Why?
Integrases
1
2024
123
0.060
 Why?
Flow Cytometry
3
2015
1085
0.060
 Why?
Tablets
1
2022
35
0.050
 Why?
Quality of Health Care
1
2007
586
0.050
 Why?
Creatinine
3
2018
491
0.050
 Why?
Drug Therapy, Combination
2
2018
965
0.050
 Why?
Habits
1
2022
38
0.050
 Why?
Sex Characteristics
1
2007
671
0.050
 Why?
Mental Health
2
2019
568
0.050
 Why?
Cells, Cultured
4
2017
4077
0.050
 Why?
Drug Prescriptions
1
2004
248
0.050
 Why?
Voltage-Dependent Anion Channel 1
1
2021
9
0.050
 Why?
Angina Pectoris
1
2001
63
0.050
 Why?
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
1
2021
44
0.050
 Why?
Citrate (si)-Synthase
1
2021
49
0.050
 Why?
Drug Monitoring
1
2022
187
0.050
 Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
36
0.050
 Why?
Antigens, Viral
3
2014
181
0.050
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
79
0.050
 Why?
Diagnosis-Related Groups
1
2000
30
0.050
 Why?
Weight Loss
2
2020
655
0.050
 Why?
Hemarthrosis
1
2000
12
0.050
 Why?
Hand Strength
1
2021
99
0.050
 Why?
Actigraphy
1
2020
80
0.050
 Why?
Weight Gain
1
2024
493
0.050
 Why?
Death
1
2021
105
0.050
 Why?
HIV Antigens
2
2015
17
0.050
 Why?
Communicable Diseases
1
2002
132
0.050
 Why?
Heart Valves
1
2000
44
0.050
 Why?
Virus Diseases
1
2002
198
0.040
 Why?
Immunophenotyping
3
2007
278
0.040
 Why?
Feasibility Studies
1
2022
749
0.040
 Why?
Superoxide Dismutase
1
2021
339
0.040
 Why?
Phenotype
3
2016
3003
0.040
 Why?
Drug Combinations
1
2020
291
0.040
 Why?
Benchmarking
1
2020
172
0.040
 Why?
Hemophilia A
1
2000
71
0.040
 Why?
Amino Acid Motifs
2
2014
200
0.040
 Why?
Sickness Impact Profile
1
1999
51
0.040
 Why?
Age Factors
3
2000
2995
0.040
 Why?
Survivors
1
2022
418
0.040
 Why?
Regression Analysis
2
2007
983
0.040
 Why?
Bayes Theorem
1
2020
344
0.040
 Why?
Capsules
1
2018
35
0.040
 Why?
Likelihood Functions
2
1999
136
0.040
 Why?
Nanomedicine
1
2018
28
0.040
 Why?
Herpesviridae Infections
1
1999
142
0.040
 Why?
Early Detection of Cancer
1
2022
360
0.040
 Why?
Aged, 80 and over
2
2021
6561
0.040
 Why?
Renal Insufficiency
1
2000
150
0.040
 Why?
Uganda
1
2018
74
0.040
 Why?
Chemistry Techniques, Analytical
1
2018
18
0.040
 Why?
Chemoprevention
1
2018
89
0.040
 Why?
Drug Compounding
1
2018
90
0.040
 Why?
Oxazines
1
2018
25
0.040
 Why?
Metabolic Clearance Rate
1
2018
113
0.040
 Why?
Machine Learning
1
2021
331
0.040
 Why?
Histoplasmosis
1
1997
15
0.040
 Why?
Fluconazole
1
1997
16
0.040
 Why?
Severity of Illness Index
3
2000
2674
0.040
 Why?
Fibrin Fibrinogen Degradation Products
1
2018
79
0.040
 Why?
Heart Diseases
2
2000
341
0.040
 Why?
Palatine Tonsil
1
2017
32
0.040
 Why?
Adaptation, Physiological
1
2021
502
0.040
 Why?
Fatigue
1
2019
297
0.040
 Why?
Cause of Death
1
2019
380
0.040
 Why?
Computer Simulation
2
2016
922
0.040
 Why?
Internet
1
2002
633
0.040
 Why?
Cardiology Service, Hospital
1
1997
29
0.040
 Why?
Inosine Triphosphate
1
2016
3
0.040
 Why?
Anemia, Hemolytic
1
2016
19
0.040
 Why?
Perforin
1
2016
19
0.040
 Why?
Primary Health Care
1
2007
1560
0.040
 Why?
Pyridones
1
2018
119
0.040
 Why?
Guanosine Triphosphate
1
2016
87
0.040
 Why?
Antifungal Agents
1
1997
134
0.040
 Why?
Half-Life
1
2016
147
0.040
 Why?
Randomized Controlled Trials as Topic
1
2022
1244
0.040
 Why?
Lung
2
2022
3664
0.040
 Why?
Lymphocyte Depletion
1
2016
119
0.040
 Why?
Models, Theoretical
1
2000
556
0.040
 Why?
Nucleotides
1
2016
112
0.030
 Why?
Eating
1
1999
369
0.030
 Why?
Peru
1
2016
59
0.030
 Why?
Intubation, Intratracheal
1
1998
226
0.030
 Why?
Spermatozoa
1
2016
91
0.030
 Why?
Statistics, Nonparametric
2
2012
403
0.030
 Why?
Clinical Protocols
1
1997
238
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2021
1171
0.030
 Why?
Child
6
2017
19129
0.030
 Why?
Algorithms
2
2011
1541
0.030
 Why?
Forkhead Transcription Factors
1
2016
182
0.030
 Why?
Animals
4
2016
33381
0.030
 Why?
Heart Valve Prosthesis Implantation
1
1998
189
0.030
 Why?
South Africa
1
2016
163
0.030
 Why?
Human Activities
1
2015
20
0.030
 Why?
Piperazines
1
2018
316
0.030
 Why?
Receptors, CXCR4
2
2007
81
0.030
 Why?
United States
5
2016
12555
0.030
 Why?
HEK293 Cells
1
2017
625
0.030
 Why?
Receptors, CXCR5
1
2014
11
0.030
 Why?
Receptors, CCR7
1
2014
24
0.030
 Why?
Drug Users
1
2015
39
0.030
 Why?
Blood
1
2015
100
0.030
 Why?
Drug Administration Schedule
1
2016
736
0.030
 Why?
Cathelicidins
1
2014
39
0.030
 Why?
Adenosine Triphosphate
1
2016
439
0.030
 Why?
Registries
1
2022
1810
0.030
 Why?
Substance Abuse, Intravenous
1
2015
80
0.030
 Why?
Polymerase Chain Reaction
2
2012
1012
0.030
 Why?
Complementarity Determining Regions
1
2014
45
0.030
 Why?
Mutation Rate
1
2014
25
0.030
 Why?
Gene Expression Regulation, Viral
1
2014
84
0.030
 Why?
Aging, Premature
1
2013
11
0.030
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
38
0.030
 Why?
Energy Metabolism
1
1999
767
0.030
 Why?
Prognosis
1
2021
3443
0.030
 Why?
Body Fat Distribution
1
2013
45
0.030
 Why?
Kidney Failure, Chronic
1
1999
516
0.030
 Why?
Infant, Newborn
2
1994
5255
0.030
 Why?
Cytotoxicity, Immunologic
2
2007
204
0.030
 Why?
Amino Acid Substitution
1
2014
276
0.030
 Why?
Mothers
1
1999
682
0.030
 Why?
Cardiac Surgical Procedures
1
1997
461
0.030
 Why?
Frail Elderly
1
2013
107
0.030
 Why?
Genotype
2
2012
1882
0.030
 Why?
Bronchoalveolar Lavage Fluid
1
2015
613
0.030
 Why?
Child, Preschool
3
1998
9491
0.030
 Why?
Cyclopropanes
1
2012
80
0.030
 Why?
Muscles
1
2013
333
0.030
 Why?
Alkynes
1
2012
56
0.030
 Why?
Receptors, HIV
1
2011
23
0.030
 Why?
Confidence Intervals
1
2012
324
0.030
 Why?
Insulin-Like Growth Factor I
1
2013
287
0.020
 Why?
Depression
1
2019
1132
0.020
 Why?
Disabled Persons
1
2013
147
0.020
 Why?
Postoperative Complications
1
2001
2235
0.020
 Why?
Infant
2
1994
8293
0.020
 Why?
Pregnancy Complications, Infectious
1
1994
296
0.020
 Why?
Epithelial Cells
1
2016
963
0.020
 Why?
Follow-Up Studies
2
2015
4596
0.020
 Why?
Bone and Bones
1
2013
289
0.020
 Why?
Geography
1
2011
190
0.020
 Why?
North America
1
2011
266
0.020
 Why?
Body Mass Index
2
2013
2092
0.020
 Why?
Disease Susceptibility
1
2012
331
0.020
 Why?
Interleukin-2
2
2003
416
0.020
 Why?
Chi-Square Distribution
2
2002
525
0.020
 Why?
Bone Density
1
2013
449
0.020
 Why?
Cost-Benefit Analysis
1
2012
554
0.020
 Why?
Cell Proliferation
1
2016
2275
0.020
 Why?
Models, Biological
1
2016
1715
0.020
 Why?
Postoperative Hemorrhage
2
2000
79
0.020
 Why?
Magnetic Resonance Imaging
1
2000
3174
0.020
 Why?
Respiratory Tract Diseases
2
2000
143
0.020
 Why?
DNA, Viral
2
2000
356
0.020
 Why?
Socioeconomic Factors
1
2012
1129
0.020
 Why?
Immunosuppressive Agents
1
2012
681
0.020
 Why?
Health Status
2
2004
726
0.020
 Why?
Personnel Turnover
1
2007
27
0.020
 Why?
Lymphocyte Count
1
2007
136
0.020
 Why?
Sweating
1
2007
24
0.020
 Why?
Gene Expression Regulation
1
2016
2445
0.020
 Why?
DNA Primers
1
2008
533
0.020
 Why?
Risk Assessment
3
2004
3057
0.020
 Why?
Hospital Mortality
2
2004
814
0.020
 Why?
Gender Identity
1
2007
102
0.020
 Why?
Obesity
1
1999
2746
0.020
 Why?
Fever
1
2007
283
0.020
 Why?
Neoplasms
1
2019
2179
0.020
 Why?
Health Care Surveys
1
2007
546
0.020
 Why?
Selection Bias
1
2005
35
0.020
 Why?
DNA
1
2012
1388
0.020
 Why?
Acute Disease
1
2007
940
0.020
 Why?
Quality Indicators, Health Care
1
2007
295
0.020
 Why?
Cell Line
2
2001
2707
0.020
 Why?
HLA-A3 Antigen
1
2003
6
0.020
 Why?
Base Sequence
1
2008
2159
0.020
 Why?
HLA-B7 Antigen
1
2003
8
0.020
 Why?
Intraoperative Care
1
2004
39
0.010
 Why?
HLA-A2 Antigen
1
2003
39
0.010
 Why?
Superantigens
1
2003
68
0.010
 Why?
Double-Blind Method
1
2008
1687
0.010
 Why?
Histocompatibility Testing
1
2003
123
0.010
 Why?
Cell Line, Transformed
1
2003
136
0.010
 Why?
Virus Activation
1
2003
80
0.010
 Why?
B7-2 Antigen
1
2002
25
0.010
 Why?
Postoperative Period
1
2004
309
0.010
 Why?
Drug Evaluation, Preclinical
1
2003
180
0.010
 Why?
Chronic Disease
1
2009
1636
0.010
 Why?
Morbidity
1
2004
296
0.010
 Why?
Pregnancy
1
1994
5690
0.010
 Why?
Hospital-Physician Relations
1
2002
2
0.010
 Why?
Parainfluenza Virus 3, Human
1
2002
5
0.010
 Why?
Community Medicine
1
2002
5
0.010
 Why?
Rotavirus
1
2002
26
0.010
 Why?
CD40 Antigens
1
2002
80
0.010
 Why?
Attitude to Computers
1
2002
27
0.010
 Why?
Streptococcus pyogenes
1
2002
35
0.010
 Why?
Sick Role
1
2001
19
0.010
 Why?
HIV Core Protein p24
1
2001
28
0.010
 Why?
Immunity, Cellular
1
2003
270
0.010
 Why?
Preoperative Care
1
2004
332
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2003
827
0.010
 Why?
Respiratory Syncytial Virus, Human
1
2002
61
0.010
 Why?
Health Services Research
1
2004
385
0.010
 Why?
Phosphorus Radioisotopes
1
2000
29
0.010
 Why?
Community-Acquired Infections
1
2002
143
0.010
 Why?
Antigens, CD
1
2002
460
0.010
 Why?
United States Department of Veterans Affairs
1
2004
555
0.010
 Why?
Hemophilia B
1
2000
35
0.010
 Why?
Knee
1
2000
52
0.010
 Why?
Elbow
1
2000
54
0.010
 Why?
Synovial Membrane
1
2000
71
0.010
 Why?
Ankle
1
2000
71
0.010
 Why?
Hyperplasia
1
2000
170
0.010
 Why?
Seasons
1
2002
461
0.010
 Why?
Activities of Daily Living
1
2001
354
0.010
 Why?
Calorimetry, Indirect
1
1999
72
0.010
 Why?
Research Design
1
2005
969
0.010
 Why?
Diet Records
1
1999
81
0.010
 Why?
Fathers
1
1999
47
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
1998
46
0.010
 Why?
Cost Control
1
1998
44
0.010
 Why?
Mice, Transgenic
1
2003
2025
0.010
 Why?
Anthropometry
1
1999
194
0.010
 Why?
Erythrocyte Transfusion
1
2000
210
0.010
 Why?
Absorptiometry, Photon
1
1999
229
0.010
 Why?
Puberty
1
1999
144
0.010
 Why?
Radiography
1
2000
861
0.010
 Why?
Reproducibility of Results
1
2005
2874
0.010
 Why?
Analysis of Variance
1
2000
1293
0.010
 Why?
Streptokinase
1
1996
11
0.010
 Why?
Phytohemagglutinins
1
1996
27
0.010
 Why?
Tetanus Toxoid
1
1996
37
0.010
 Why?
Candida
1
1996
35
0.010
 Why?
Postoperative Care
1
1998
237
0.010
 Why?
Cell Division
1
1998
776
0.010
 Why?
Antigens, Bacterial
1
1996
116
0.010
 Why?
Exercise Test
1
1999
551
0.010
 Why?
Survival Rate
1
2000
1720
0.010
 Why?
Disease-Free Survival
1
1997
649
0.010
 Why?
Nuclear Proteins
1
1999
597
0.010
 Why?
Logistic Models
1
2000
1901
0.010
 Why?
Adipose Tissue
1
1999
606
0.010
 Why?
Databases, Factual
1
1999
1231
0.010
 Why?
Patient Selection
1
1997
676
0.010
 Why?
Prevalence
1
1999
2326
0.010
 Why?
Recombinant Proteins
1
1996
1308
0.010
 Why?
Mice
1
2003
15520
0.000
 Why?
MaWhinney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (499) concept(s)
_
Co-Authors Expand Description
See all (67) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)